These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33468238)

  • 1. Drug synergy scoring using minimal dose response matrices.
    Mäkelä P; Zhang SM; Rudd SG
    BMC Res Notes; 2021 Jan; 14(1):27. PubMed ID: 33468238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Ozseven AG; Sesli Çetin E; Ozseven L
    Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.
    Malyutina A; Majumder MM; Wang W; Pessia A; Heckman CA; Tang J
    PLoS Comput Biol; 2019 May; 15(5):e1006752. PubMed ID: 31107860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico drug combination discovery for personalized cancer therapy.
    Jeon M; Kim S; Park S; Lee H; Kang J
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Synergy Prediction Using Dynamic Mutation Based Differential Evolution.
    Kaur M; Singh D; Kumar V
    Curr Pharm Des; 2021; 27(8):1103-1111. PubMed ID: 33155903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.
    White RL; Burgess DS; Manduru M; Bosso JA
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1914-8. PubMed ID: 8843303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
    Österroos A; Kashif M; Haglund C; Blom K; Höglund M; Andersson C; Gustafsson MG; Eriksson A; Larsson R
    Biochem Pharmacol; 2016 Oct; 118():40-49. PubMed ID: 27565890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of drug combination effects with a minimal set of experiments.
    Ianevski A; Giri AK; Gautam P; Kononov A; Potdar S; Saarela J; Wennerberg K; Aittokallio T
    Nat Mach Intell; 2019 Dec; 1(12):568-577. PubMed ID: 32368721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratification and prediction of drug synergy based on target functional similarity.
    Yang M; Jaaks P; Dry J; Garnett M; Menden MP; Saez-Rodriguez J
    NPJ Syst Biol Appl; 2020 Jun; 6(1):16. PubMed ID: 32487991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studies.
    Whitehead A; Su TL; Thygesen H; Sperrin M; Harbron C
    Pharm Stat; 2013; 12(5):300-8. PubMed ID: 23907796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model.
    Yadav B; Wennerberg K; Aittokallio T; Tang J
    Comput Struct Biotechnol J; 2015; 13():504-13. PubMed ID: 26949479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental designs for detecting synergy and antagonism between two drugs in a pre-clinical study.
    Sperrin M; Thygesen H; Su TL; Harbron C; Whitehead A
    Pharm Stat; 2015; 14(3):216-25. PubMed ID: 25810342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-stage model-free tests of synergy in drug combinations.
    Kelly C; Feng P; Kawashima T; Wilmes A; Miller J
    J Biopharm Stat; 2012; 22(1):54-71. PubMed ID: 22204527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening.
    Chen L; Wilson K; Goldlust I; Mott BT; Eastman R; Davis MI; Zhang X; McKnight C; Klumpp-Thomas C; Shinn P; Simmons J; Gormally M; Michael S; Thomas CJ; Ferrer M; Guha R
    Sci Rep; 2016 Nov; 6():37741. PubMed ID: 27883049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for testing for synergy with any number of agents.
    Berenbaum MC
    J Infect Dis; 1978 Feb; 137(2):122-30. PubMed ID: 627734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Screening for Drug Combinations.
    Shinn P; Chen L; Ferrer M; Itkin Z; Klumpp-Thomas C; McKnight C; Michael S; Mierzwa T; Thomas C; Wilson K; Guha R
    Methods Mol Biol; 2019; 1939():11-35. PubMed ID: 30848454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charting the Fragmented Landscape of Drug Synergy.
    Meyer CT; Wooten DJ; Lopez CF; Quaranta V
    Trends Pharmacol Sci; 2020 Apr; 41(4):266-280. PubMed ID: 32113653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Flow Cytometry Drug Combination Discovery with Novel Synergy Analysis Software, SynScreen.
    Perez DR; Edwards BS; Sklar LA; Chigaev A
    SLAS Discov; 2018 Aug; 23(7):751-760. PubMed ID: 29842834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CombiANT: Antibiotic interaction testing made easy.
    Fatsis-Kavalopoulos N; Roemhild R; Tang PC; Kreuger J; Andersson DI
    PLoS Biol; 2020 Sep; 18(9):e3000856. PubMed ID: 32941420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method.
    Brennan-Krohn T; Kirby JE
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.